THE IMPACT OF VARIANT HISTOLOGY ON CLINICAL OUTCOMES AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

被引：0
|
作者：
Halstuch, Daniel
Kool, Ronald
Marcq, Gautier
Breau, Rodney H.
Black, Peter C.
Shayegan, Bobby
Kim, Michael
Busca, Ionut
Abdi, Hamidreza
Dawidek, Mark T.
Uy, Michael
Fervaha, Gagan
Cury, Fabio L.
Alimohamed, Nimira S.
Jeldres, Claudio
Rendon, Ricardo
Siemens, D. Robert
Kulkarni, Girish S.
Kassouf, Wassim
Izawa, Jonathan I.
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD09-02
引用
收藏
页码：E239 / E240
页数：2
相关论文
共 50 条
  • [41] A single institution experience of multimodality radiation therapy for muscle-invasive bladder cancer
    Nair, Monica
    Scarborough, Jessica
    Gupta, Shilpa
    Gilligan, Timothy D.
    Nizam, Amanda
    Ornstein, Moshe Chaim
    Echle, Jessica
    Ciezki, Jay P.
    Stephans, Kevin L.
    Tendulkar, Rahul D.
    Scott, Jacob
    Mian, Omar Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Evaluating biparametric MRI for diagnosing muscle-invasive bladder cancer with variant urothelial histology: a multicenter study
    Liu, Peikun
    Cai, Lingkai
    Que, Hongliang
    Jiang, Meihua
    Jiang, Xuping
    Liang, Bo
    Wang, Gongcheng
    Jiang, Linjing
    Yang, Xiao
    Lu, Qiang
    CANCER IMAGING, 2025, 25 (01)
  • [43] Investigating the role of neutrophils in muscle-invasive bladder cancer and response to radiation therapy
    Fehric, Sabina
    Michaud, Eva
    Shinde-Jadhav, Surashri
    Huang, JiaMin
    Mansure, Jose J.
    Rayes, Roni
    Spicer, Jonathan
    Kassouf, Wassim
    CANCER RESEARCH, 2022, 82 (12)
  • [44] CHARACTERIZATION OF THE GENOMIC LANDSCAPE OF A PROSPECTIVE MUSCLE-INVASIVE BLADDER CANCER COHORT WITH A FOCUS ON SECONDARY VARIANT HISTOLOGY
    Narayan, Vikram
    Gibb, Ewan
    Erho, Nicholas
    Cronican, Andrea
    Kolisnik, Tyler
    Davicioni, Elai
    Konety, Badrinath
    JOURNAL OF UROLOGY, 2018, 199 (04): : E310 - E310
  • [45] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Johnson, Skyler B.
    Yu, James B.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [46] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Chen, Ronald C.
    Shipley, William U.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
  • [47] Survival outcomes of non-definitive therapy for muscle-invasive bladder cancer
    Nishihara, Kiyoaki
    Ueda, Kosuke
    Kurose, Hirofumi
    Ogasawara, Naoyuki
    Hiroshige, Tasuku
    Chikui, Katsuaki
    Ejima, Kazuhisa
    Uemura, Keiichiro
    Nakiri, Makoto
    Suekane, Shigetaka
    Igawa, Tsukasa
    ONCOLOGY LETTERS, 2022, 23 (04)
  • [48] The optimal management of variant histology in muscle invasive bladder cancer
    Tiwari, Raj Vikesh
    Ngo, Nye Thane
    Lee, Lui Shiong
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2965 - 2975
  • [49] Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Efstathiou, Jason A.
    Mouw, Kent W.
    Gibb, Ewan A.
    Liu, Yang
    Wu, Chin-Lee
    Drumm, Michael R.
    da Costa, Jose Batista
    du Plessis, Marguerite
    Wang, Natalie Q.
    Davicioni, Elai
    Feng, Felix Y.
    Seiler, Roland
    Black, Peter C.
    Shipley, William U.
    Miyamoto, David T.
    EUROPEAN UROLOGY, 2019, 76 (01) : 59 - 68
  • [50] Impact of selection bias on outcomes in veterans with muscle-invasive bladder cancer receiving bladder preserving trimodality therapy.
    Kumar, Abhishek
    Kotha, Nikhil V.
    Nelson, Tyler J.
    Cherry, Daniel R.
    Stewart, Tyler F.
    Mckay, Rana R.
    Rose, Brent S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345